Celecoxib Capsule
Product Images NDC 11788-112

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Celecoxib (NDC 11788-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aiping Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-100s-label.jpg (100mg 100s Label)

Label for Celecoxib Capsules 100 mg by AiPing Pharmaceutical, Inc. The label indicates each capsule contains 100 mg celecoxib, with dispensing instructions to keep in child-resistant containers. It includes storage instructions for room temperature and a print medication guide website. The package quantity is 100 capsules, Rx only.*

FDA Label Image

100mg-500s-label.jpg (100mg 500s Label)

Celecoxib 100 mg capsule label from AiPing Pharmaceutical, Inc. The label states each capsule contains 100 mg celecoxib and includes storage instructions at room temperature 20°C to 25°C (68°F to 77°F) with permitted excursions. The package is Rx only and contains 500 capsules. The label also directs to dispense the medication guide to each patient and provides a manufacturer website URL.*

FDA Label Image

200mg-100s-label.jpg (200mg 100s Label)

Packaging label for Celecoxib Capsules 200 mg by AiPing Pharmaceutical, Inc. The label indicates the product contains 100 capsules and is labeled for prescription use only. It includes dosage instructions, storage temperature guidelines between 20°C to 25°C with permitted excursions, and a printed medication guide URL. The label also states the product must be dispensed in tight, child-resistant containers.*

FDA Label Image

200mg-500s-label.jpg (200mg 500s Label)

Label for Celecoxib Capsules 200 mg, oral capsules manufactured by AiPing Pharmaceutical, Inc. The label shows that the package contains 500 capsules labeled Rx Only. Storage instructions specify keeping the capsules at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The label includes a pharmacy instruction to dispense the Medication Guide to each patient and provides a website URL for the medication guide.*

FDA Label Image

400mg-60s-label.jpg (400mg 60s Label)

Celecoxib Capsules 400 mg oral capsules package label. The label shows the strength as 400 mg, contains 60 capsules, and is manufactured by AiPing Pharmaceutical, Inc. The label includes storage instructions, dispensing information, and a barcode.*

FDA Label Image

50mg-60s-label.jpg (50mg 60s Label)

Celecoxib Capsules 50 mg oral capsules packaging label from AiPing Pharmaceutical, Inc. The label displays the strength as 50 mg, with a package count of 60 capsules. It includes dosage information stating each capsule contains 50 mg celecoxib and storage instructions for room temperature. There is a barcode on the right side and usage guidance for pharmacists.*

FDA Label Image

Chemical-structure.jpg (Chemical Structure)

Chemical structure of celecoxib, showing its molecular framework including sulfonamide and trifluoromethyl functional groups attached to aromatic rings and a pyrazole moiety.*

FDA Label Image

Table3-2 (Table 3 2)

A drug facts text panel presenting clinical information about Celecoxib capsules. It summarizes key warnings and precautions, including risks of gastrointestinal bleeding, cardiovascular effects, and drug interactions, particularly when used with warfarin or corticosteroids. The text details conditions under which caution or adjustment may be necessary.*

FDA Label Image

Table (Table)

A data table comparing the incidence percentages of specific adverse reactions between Celecoxib (400 to 800 mg daily) and placebo groups in clinical study populations, listing events such as diarrhea, gastroesophageal reflux disease, nausea, vomiting, dyspnea, hypertension, and nephrolithiasis.*

FDA Label Image

Table1 (Table1)

Table presenting adverse events occurring in 2% or more of patients treated with Celecoxib and comparators (placebo, naproxen, diclofenac, ibuprofen) in pre-marketing controlled arthritis trials. It reports percentages of gastrointestinal, body, nervous system, psychiatric, respiratory, and skin adverse events among the study groups.*

FDA Label Image

Table2 (Table2)

Table showing adverse events occurring in 5% or more of Juvenile Rheumatoid Arthritis (JRA) patients by system organ class for Celecoxib at doses 3 mg/kg and 6 mg/kg, and Naproxen at 7.5 mg/kg, with the percentage of patients experiencing events in each treatment group across categories such as eye disorders, gastrointestinal, general, infections, injury and poisoning, investigations, musculoskeletal, nervous system, respiratory, and skin and subcutaneous events.*

FDA Label Image

Image Description (Table3 1)

A data table titled 'Table 3. Clinically Significant Drug Interactions with Celecoxib' listing various drugs (e.g., Aspirin, ACE inhibitors, Angiotensin Receptor Blockers, Beta-Blockers, Lithium, Methotrexate, Cyclosporine, Diuretics, NSAIDs and Salicylates, Paroxetine) alongside their clinical effects, explanations, and interventions relevant to celecoxib. The table describes potential pharmacodynamic and pharmacokinetic interactions and provides guidance on monitoring and dose adjustments when celecoxib is used concomitantly with these drugs.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.